A PHASE 2 OPEN-LABEL, MULTICENTER CLINICAL STUDY OF THE SAFETY, EFFICACY, PHARMACOKINETIC, AND PHARMACODYNAMIC PROFILES OF CGT9486 AS A SINGLE AGENT IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS
ENROLLING
Trial ID:
NCT04996875 Protocol # :
21-358
Phase
II
Disease Sites
Other Hematopoietic
Non-Hodgkin's Lymphoma
Hodgkin's Lymphoma
Multiple Myeloma
Lymphoid Leukemia
Myeloid and Monocytic Leukemia
Leukemia, other
Principal Investigator
DeAngelo, Daniel, J
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #21-358
21-358